CCS ≥ 1, no. of patients | 204 | 744 |
CCS < 1, no. of patients | 1* | 109 |
Sensitivity, % (95% CI) | 99.5 (97.3–99.9) | |
Negative predictive value, % (95% CI) | 99.1 (93.9–99.9) | |
Negative likelihood ratio (95% CI) | 0.04 (0.01–0.27) | |
Specificity, % (95% CI) | 12.8 (10.6–15.2) | |
Positive predictive value, % (95% CI) | 21.5 (21.1–21.9) | |
Positive likelihood ratio (95% CI) | 1.14 (1.11–1.17) | |
hs-cTnI ≥ 1 ng/L, no. of patients | 187 | 519 |
hs-cTnI < 1 ng/L, no. of patients | 18 | 334 |
Sensitivity, % (95% CI) | 91.2 (86.5–94.7) | |
Negative predictive value, % (95% CI) | 94.9 (92.2–96.7) | |
Negative likelihood ratio (95% CI) | 0.22 (0.14–0.35) | |
Specificity, % (95% CI) | 39.2 (35.9–42.5) | |
Positive predictive value, % (95% CI) | 26.5 (25.2–27.8) | |
Positive likelihood ratio (95% CI) | 1.50 (1.40–1.61) | |
hs-cTnI ≥ 5 ng/L, no. of patients | 152 | 183 |
hs-cTnI < 5 ng/L, no. of patients | 53 | 669 |
Sensitivity, % (95% CI) | 74.2 (67.6–80.0) | |
Negative predictive value, % (95% CI) | 92.7 (90.9–94.1) | |
Negative likelihood ratio (95% CI) | 0.33 (0.26–0.42) | |
Specificity, % (95% CI) | 78.5 (75.6–81.2) | |
Positive predictive value, % (95% CI) | 45.4 (41.6–49.1) | |
Positive likelihood ratio (95% CI) | 3.45 (2.97–4.02) | |
CCS = 5, no. of patients | 58 | 19 |
CCS < 5, no. of patients | 147 | 834 |
Specificity, % (95% CI) | 97.8 (96.5–98.7) | |
Positive predictive value, % (95% CI) | 75.3 (65.0–83.4) | |
Positive likelihood ratio (95% CI) | 12.7 (7.74–20.8) | |
Sensitivity, % (95% CI) | 28.3 (22.2–34.9) | |
Negative predictive value, % (95% CI) | 85.0 (83.9–86.1) | |
Negative likelihood ratio (95% CI) | 0.73 (0.67–0.80) | |
hs-cTnI > 11 ng/L, no. of patients | 132 | 84 |
hs-cTnI ≤ 11 ng/L, no. of patients | 73 | 768 |
Specificity, % (95% CI) | 90.1 (87.9–92.0) | |
Positive predictive value, % (95% CI) | 61.1 (55.6–66.4) | |
Positive likelihood ratio (95% CI) | 6.5 (5.2–8.2) | |
Sensitivity, % (95% CI) | 64.4 (57.4–70.9) | |
Negative predictive value, % (95% CI) | 91.3 (89.7–92.7) | |
Negative likelihood ratio (95% CI) | 0.39 (0.33–0.47) | |